Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Alicia Roldán Pérez"'
Autor:
Alicia Roldán Pérez, Juan Andrés Vázquez Paganini, M. José Penalva Moreno, Eugenio Giménez Mesa, Alba Sara Vilches Moreno, Claudia Nuñez‐Torrón Stock, Regina Herráez García
Publikováno v:
Clinical Case Reports, Vol 10, Iss 7, Pp n/a-n/a (2022)
Abstract We report our experience with venetoclax/hypomethylating agents (Ven/HMA) in 8 AML patients not candidates for intensive CT or refractory/relapsed with limited treatment options. The response rate was 50%. Venetoclax was well‐tolerated in
Externí odkaz:
https://doaj.org/article/549dce02f60447d983f011044ffef307
Autor:
José Luis Piñana, Lourdes Vazquez, Inmaculada Heras, Tommaso Francesco Aiello, Lucia López-Corral, Ignacio Arroyo, Eva Soler-Espejo, Irene García-Cadenas, Valentín Garcia-Gutierrez, Cristina Aroca, Pedro Chorao, María T. Olave, Javier Lopez-Jimenez, Marina Acera Gómez, Elena Arellano, Marian Cuesta-Casas, Alejandro Avendaño-Pita, Clara González-Santillana, José Ángel Hernández-Rivas, Alicia Roldán-Pérez, Mireia Mico-Cerdá, Manuel Guerreiro, Julia Morell, Paula Rodriguez-Galvez, Jorge Labrador, Diana Campos, Ángel Cedillo, Carolina Garcia Vidal, Rodrigo Martino, Carlos Solano
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionScarce real-life data exists for COVID-19 management in hematologic disease (HD) patients in the Omicron era.PurposeTo assess the current clinical management and outcome of SARS-CoV-2 infection diagnosed, identify the risk factors for sev
Externí odkaz:
https://doaj.org/article/c7e1fc043ebf4586b4a5741faa4b32e6
Autor:
José Luis Piñana, Lourdes Vazquez, Marisa Calabuig, Lucia López-Corral, Gabriel Martin-Martin, Lucia Villalon, Gabriela Sanz-Linares, Venancio Conesa-Garcia, Andrés Sanchez-Salinas, Beatriz Gago, Ana Facal, Irene Risco-Gálvez, María T. Olave, Ildefonso Espigado, Javier Lopez-Jimenez, José Ángel Hernández-Rivas, Alejandro Avendaño-Pita, Ignacio Arroyo, Elena Ferrer, Irene García-Cadenas, Clara González-Santillana, Alicia Roldán-Pérez, Blanca Ferrer, Manuel Guerreiro, María Suarez-Lledó, Angela Camara, Diana Campos-Beltrán, David Navarro, Ángel Cedillo, Anna Sureda, Carlos Solano, Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC), Rodrigo Martino
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-14 (2023)
Abstract The long-term clinical efficacy of SARS-CoV-2 vaccines according to antibody response in immunosuppressed patients such as hematological patients has been little explored. A prospective multicenter registry-based cohort study conducted from
Externí odkaz:
https://doaj.org/article/da41ce1978d245428ba9b7f45cad2ea8
Autor:
Jorge Labrador, David Martínez-Cuadrón, Adolfo de la Fuente, Rebeca Rodríguez-Veiga, Josefina Serrano, Mar Tormo, Eduardo Rodriguez-Arboli, Fernando Ramos, Teresa Bernal, María López-Pavía, Fernanda Trigo, María Pilar Martínez-Sánchez, Juan-Ignacio Rodríguez-Gutiérrez, Carlos Rodríguez-Medina, Cristina Gil, Daniel García Belmonte, Susana Vives, María-Ángeles Foncillas, Manuel Pérez-Encinas, Andrés Novo, Isabel Recio, Gabriela Rodríguez-Macías, Juan Miguel Bergua, Víctor Noriega, Esperanza Lavilla, Alicia Roldán-Pérez, Miguel A. Sanz, Pau Montesinos, on behalf of PETHEMA Group
Publikováno v:
Cancers, Vol 14, Iss 9, p 2342 (2022)
The hypomethylating agents, decitabine (DEC) and azacitidine (AZA), allowed more elderly acute myeloid leukemia (AML) patients to be treated. However, there are little direct comparative data on AZA and DEC. This multicenter retrospective study compa
Externí odkaz:
https://doaj.org/article/0cf344d29c524010a92f259ca9e9d33d
Autor:
Jorge Labrador, Miriam Saiz-Rodríguez, Dunia de Miguel, Almudena de Laiglesia, Carlos Rodríguez-Medina, María Belén Vidriales, Manuel Pérez-Encinas, María José Sánchez-Sánchez, Rebeca Cuello, Alicia Roldán-Pérez, Susana Vives, Gonzalo Benzo-Callejo, Mercedes Colorado, María García-Fortes, María José Sayas, Carmen Olivier, Isabel Recio, Diego Conde-Royo, Álvaro Bienert-García, María Vahi, Carmen Muñoz-García, Cristina Seri-Merino, Mar Tormo, Ferran Vall-llovera, María-Ángeles Foncillas, David Martínez-Cuadrón, Miguel Ángel Sanz, Pau Montesinos
Publikováno v:
Cancers, Vol 14, Iss 7, p 1734 (2022)
The effectiveness of venetoclax (VEN) in relapsed or refractory acute myeloid leukemia (RR-AML) has not been well established. This retrospective, multicenter, observational database studied the effectiveness of VEN in a cohort of 51 RR-AML patients
Externí odkaz:
https://doaj.org/article/7ba43b825955419eaaafe4e67da06e42
Autor:
José Luis, Piñana, Lourdes, Vazquez, Marisa, Calabuig, Lucia, López-Corral, Gabriel, Martin-Martin, Lucia, Villalon, Gabriela, Sanz-Linares, Venancio, Conesa-Garcia, Andrés, Sanchez-Salinas, Beatriz, Gago, Ana, Facal, Irene, Risco-Gálvez, María T, Olave, Ildefonso, Espigado, Javier, Lopez-Jimenez, José Ángel, Hernández-Rivas, Alejandro, Avendaño-Pita, Ignacio, Arroyo, Elena, Ferrer, Irene, García-Cadenas, Clara, González-Santillana, Alicia, Roldán-Pérez, Blanca, Ferrer, Manuel, Guerreiro, María, Suarez-Lledó, Angela, Camara, Diana, Campos-Beltrán, David, Navarro, Ángel, Cedillo, Anna, Sureda, Carlos, Solano, Rodrigo, Martino
Publikováno v:
Blood cancer journal. 13(1)
The long-term clinical efficacy of SARS-CoV-2 vaccines according to antibody response in immunosuppressed patients such as hematological patients has been little explored. A prospective multicenter registry-based cohort study conducted from December
Autor:
Raquel Ramos Corral, Nazaret del Amo del Arco, Yessika M. Amezquita Orjuela, Javier López Flores, Alicia Roldán Pérez, Fernando Cava Valenciano
Publikováno v:
Revista del Laboratorio Clínico. 12:128-132
Resumen El tratamiento con metotrexato (MTX) a dosis elevadas implica una monitorizacion estrecha de los niveles del farmaco para confirmar su correcta eliminacion. Uno de los posibles efectos secundarios es el fracaso renal, lo que ocasiona una acum
Autor:
Erik de Cabo López, María Teresa Olave, Alicia Roldán Pérez, Teresa Bernal del Castillo, Miguel A. Sanz, Pilar Rodríguez Martínez, Jesús Lorenzo Algarra, Josefina Serrano, Susana Vives, María Carmen Mateos Rodríguez, María-Belén Vidriales, Cristina Seri, Isabel Cano, Cristian Escolano Escobar, Marta Cervera, Pau Montesinos, Angela Figuera Alvarez, Jose Luiz Lopez Lorenzo, Jose Luis Piñana Sanchez, Maria Angeles Foncillas, Juan Miguel Bergua Burgues, Carlos Cerveró, Montserrat Arnan Sangerman, Laida Cuevas Palomares, Marta Sobas, Javier Cornago Navascués, Almudena de Laiglesia, Paola Sandra Villafuerte Gutierrez, Villegas A, Maria Dunia De Miguel, Pilar Herrera Puente, María Josefa Najera Irazu, Carmen Botella, Maria Lourdes Hermosin, María Elena Amutio Diez, Gabriela Rodríguez-Macías, Joaquin Martinez-Lopez, Tomás Palanques Pastor, Begoña Navas, Alejandro Contento-Gonzalo, Rebeca Cuello, Raimundo García-Boyero
Publikováno v:
Blood
SARS-CoV-2 infection can impact survival of patients with acute myeloid leukemia (AML). International experts recommend considering delaying or stopping AML treatment, test patients who need intensive induction and s prioritizing outpatient treatment
Autor:
Joaquin Martinez-Lopez, Laida Cuevas Palomares, Pilar Rodríguez Martínez, María Belén Vidriales Vicente, Susana Vives, Raimundo Garcia Boyero, Isabel Cano, Lourdes Hermosín Ramos, María Carmen Mateos Rodríguez, Cristian Escolano Escobar, María Telesa Olave, Cristina Seri Merino, Montserrat Arnan Sangerman, Juan Miguel Bergua Burgues, Marta Cervera Calvo, María Elena Amutio Diez, Javier Cornago Navascués, Jose Luis Lopez Lorenzo, Miguel A. Sanz, Carmen Botella Prieto, José Luis Piñana, Josefina Serrano, Almudena de Laiglesiai, Jesús Lorenzo Algarra, Alejandro Contento Gonzalo, Pau Montesinos, Carlos Cerveró, Pilar Herrera, Rebeca Cuello García, Gabriela Rodriguez Macias, Marta Sobas, Angela Figuera Alvarez, Begona Navas Elorza, María Josefa Najera Irazu, Maria Angeles Foncillas, Dunia De Miguel Llorente, Erik de Cabo López, Alicia Roldán Pérez, Teresa Bernal del Castillo, Juan Eduardo Megías-Vericat, Paola Sandra Villafuerte Gutierrez, Villegas A, Tomás Palanques-Pastor
Publikováno v:
Leukemia & lymphoma
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA & LYMPHOMA
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
LEUKEMIA & LYMPHOMA
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces higher morbidity and mortality in hematological malignancies, but evidence in acute myeloid leukemia (AML) is scarce. A multicenter observational study was conducted to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2213676a4f3ebf8d1e2cd0a70b6679f
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14915
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14915
Autor:
Teresa Bernal del Castillo, Juan Miguel Bergua Burgues, José A. Pérez-Simón, Susana Vives, Gabriela Rodriguez Macias, Pau Montesinos, Alicia Roldán Pérez, Manuel Perez Encinas, Andrés Novo, C. Rodriguez, Adolfo de la Fuente, Daniel F. Garcia, Josefina Serrano, María López-Pavía, David Martínez-Cuadrón, Juan Ignacio Rodriguez-Gutierrez, Fernando Ramos, Fernanda Trigo, Maria Angeles Foncillas, Miguel A. Sanz, Jorge Labrador, Rebeca Rodríguez-Veiga, Esperanza Lavilla, Mar Tormo, Victor Noriega Concepcion, Cristina Gil, Pilar Martinez Sanchez, Isabel Recio
Publikováno v:
Blood. 138:1256-1256
INTRODUCTION The hypomethylating agents (HMAs), decitabine (DEC) and azacitidine (AZA), have made it possible to treat more elderly patients with acute myeloid leukemia (AML). Both HMAs have demonstrated efficacy in monotherapy and in combination wit